Evidence map›Paper›PMID 40144438›Full record

ReviewCureus2025

A Narrative Review on the Role of Artificial Intelligence (AI) in Colorectal Cancer Management.

Bijily Babu, Jyoti Singh, Juan Felipe Salazar González, Sadaf Zalmai, Adnan Ahmed, Harshal D Padekar, Marina R Eichemberger, Abrar I Abdallah, Irshad Ahamed S, Zahra Nazir

Abstract readReview
In one paragraph

Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Bijily BabuClinical Research, Network Cancer Aid and Research Foundation, Cochin, IND.
Jyoti SinghDepartment of Medicine, American University of Barbados, Bridgetown, BRB.
Juan Felipe Salazar GonzálezGeneral Medicine, Clínica Renovar, Villavicencio, COL.
Sadaf ZalmaiEmergency Medicine, New York Presbyterian Hospital, New York, USA.
Adnan AhmedMedicine and Surgery, York University, Bradford, CAN.
Harshal D PadekarGeneral Surgery, Grant Medical College and Sir Jamshedjee Jeejeebhoy Group of Hospitals, Mumbai, IND.
Marina R EichembergerGeneral Surgery, Centro Universitário São Camilo, São Paulo, BRA.
Abrar I AbdallahMedicine and Surgery, Sulaiman Al Rajhi University, Al Bukayriyah, SAU.
Irshad Ahamed SGeneral Surgery, Pondicherry Institute of Medical Sciences, Pondicherry, IND.
Zahra NazirInternal Medicine, Combined Military Hospital, Quetta, PAK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of artificial intelligence (AI) tools and deep learning in medical practice in the management of colorectal cancer has gathered significant attention in recent years. Colorectal cancer, being the third most common type of malignancy, requires an innovative approach to augment early detection and advanced surgical techniques to reduce morbidity and mortality. With its emerging potential, AI improves colorectal cancer management by assisting with accuracy in screening, pathology evaluation, precision, and postoperative care. Evidence suggests that AI minimizes missed cases during colorectal cancer screening, plays a promising role in pathology and imaging diagnoses, and facilitates accurate staging. In surgical management, AI demonstrates comparable or superior outcomes to laparoscopic approaches, with reduced hospital stays and conversion rates. However, these outcomes are influenced by clinical expertise and other dependable factors, including expertise in implementing AI-based software and detecting possible errors. Despite these advancements, limited multicenter studies and randomized trials restrict the comprehensive evaluation of AI's true potential and integration into standard practice. We used Pubmed, Google Scholar, Cochrane Library, and Scopus databases for this review. The final number of articles selected, depending on inclusion and exclusion criteria, is 122. We included papers published in the English language, literature published in the last 10 years, and adult patient populations above 35 years with colorectal cancer. We thoroughly included randomized controlled trials, cohort studies, meta-analyses, systematic reviews, narrative reviews, and case-control studies. The use of AI paves the way for the adoption of more personalized medicine. This review highlights the advantages of AI at various disease stages for colorectal cancer patients and evaluates its potential for cost-effective implementation in clinical practice.

Indexed as

artifical intelligencecolon capsule endoscopycolorectal cancercomputed tomographic colonographymicrosatellite instability

Identifiers

PMID40144438
PMCPMC11940584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.